AGA Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AGA Medical's estimated annual revenue is currently $58M per year.(i)
  • AGA Medical's estimated revenue per employee is $251,000

Employee Data

  • AGA Medical has 231 Employees.(i)
  • AGA Medical grew their employee count by -18% last year.

AGA Medical's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Network ManagerReveal Email/Phone
3
Sr. Clinical Project ManagerReveal Email/Phone
4
Finance ManagerReveal Email/Phone
5
Accounts PayableReveal Email/Phone
6
LeadReveal Email/Phone
7
Human ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M1224%N/AN/A
#2
$18.6M7435%N/AN/A
#3
$75.6M30120%N/AN/A
#4
$12M484%N/AN/A
#5
$2.8M1110%N/AN/A
#6
$3M120%N/AN/A
#7
$24.6M985%N/AN/A
#8
$11.5M4621%N/AN/A
#9
$7.3M294%N/AN/A
#10
$13.8M55-10%N/AN/A
Add Company

What Is AGA Medical?

AGA Medical, based in Plymouth, Minn., is a leader in developing interventional devices for the minimally invasive treatment of structural heart defects and peripheral vascular disorders. Founded in 1995 by Dr. Kurt Amplatz, a former University of Minnesota professor and researcher, AGA Medical’s range of AMPLATZER® products help improve patient outcomes, reduce length of hospital stay and accelerate patient recovery times. AMPLATZER products significantly advanced the treatment of the most common congenital “holes in the heart,” such as atrial septal defects, patent foramen ovale and ventricular septal defects. More than 1,500 articles supporting the benefits of AMPLATZER products have been published in medical literature. AGA Medical markets AMPLATZER products in 101 countries worldwide.

keywords:N/A

N/A

Total Funding

231

Number of Employees

$58M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M23128%N/A
#2
$84.6M233-4%N/A
#3
$77.5M2438%N/A
#4
$79.1M2486%N/A
#5
$90M248-16%N/A